The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric Oxygen Therapy (HBOT) on 5 severe COVID-19 patients who developed respiratory insufficiency. HBOT mechanisms of tissue oxygenation and anti-inflammatory effect may explain these findings. The purpose of the current study is the evaluate the efficacy of HBOT in moderate-severe COVID-19 patients in a randomized controlled manner.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
SpO2
Timeframe: 5 days after randomization
NEWS Score
Timeframe: 5 days after randomization
Inflammation level -CRP
Timeframe: 5 days after randomization
white blood cells number
Timeframe: 5 days after randomization
Cytokines - IL1
Timeframe: 5 days after randomization
Cytokines - IL2
Timeframe: 5 days after randomization
Cytokines - IL6
Timeframe: 5 days after randomization
Cytokines - IL10
Timeframe: 5 days after randomization
Cytokines - TNFalpha
Timeframe: 5 days after randomization
Inflammation level - procalcitonin
Timeframe: 5 days after randomization
Inflammation level - ferritin
Timeframe: 5 days after randomization